Enhancing Stem Cell Tracking with Nanoparticle Imaging Agents
This article from Merck discusses how in vivo stem cell tracking has recently been advanced with nanoparticle-based imaging contrast agents.
Stay updated with breaking news from Osteogenic Differentiation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This article from Merck discusses how in vivo stem cell tracking has recently been advanced with nanoparticle-based imaging contrast agents.
Exploring bioactive nanocomposite microsponges for the reconstruction of critical-sized calvarial defects in rats. Click for more...
* 1Department of Orthopeadics, The Affiliated Linfen Hospital of Shanxi Medical University, Linfen, Shanxi Province, People’s Republic of China; 2Department of Orthopeadics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Province, People’s Republic of China; 3Department of Orthopeadics, The Affiliated Shunde Hospital of Jinan University, Foshan, Guangdong Province, People’s Republic of China *These authors contributed equally to this work Correspondence: Xinghua Song Department of Orthopeadics, The Affiliated Shunde Hospital of Jinan University, Foshan,...
7,8 and organ protection from ischemia/reperfusion injury. 9,10 Newly synthesized transition metal carbonyl-compounds, CO release molecules (CORMs), are effective in regulating CO release in vivo and in vitro in appropriate circumstances. 11 These CO releasing molecules can therefore be used as the new carrier to provide exogenous CO. CORM-3 [tricarbonylchloro (glycinato) ruthenium (II)] is completely soluble in water with fast release of CO when dissolved in a physiological solution. By releasing CO, CORMs also induce an anti-inflammatory effect. Our previous study showed that CORM-2 reduced...